Allium-Medical Solutions Ltd. (TASE: ALMD) acquired Gardia Medical Ltd. from Medica Venture Partners fund Poalim Ventures Ltd and others on January 30, 2012. Allium-Medical Solutions will pay 13.55% stake of Allium-Medical Solutions of ILS 12 million to Medica Venture Partners and other shareholders. Allium-Medical Solutions will also pay additional shares and cash of $2.7 million (ILS 10.1 million), subject to milestones, including the start of a clinical trial for its product, approval by the US Food and Drug Administration (FDA), and the sale of 5,000 products. Medica Venture Partners will also invest in Allium-Medical Solutions next rights issue. The currency was converted through www.oanda.com on January 30, 2012. Allium-Medical Solutions Ltd. (TASE: ALMD) completed the acquisition of Gardia Medical Ltd. from Medica Venture Partners, Poalim Ventures Ltd and others on January 30, 2012.